RESEARCH OF EFFECTIVENESS OF REVILAB ML 03
Study period — august 2018 – august 2019
Location — Russia, Moscow, Moscow office of the Peptides
Research and Production Center of Revitalization and Health
Actual enrolment — 57 participants
Dosage regimen — 41–52 y.o.
Схема приема — 1 capsule in the morning a.c. daily
Period of administration — 4 months
Number of test sessions — 32 (twice a week)
The study assessed the drug's ability to improve the adaptive capabilities of the brain tissue in
middle-aged patients when learning mnemonics using the patented methods of Matveev and
Dumchev
EFFECTIVENESS OF REVILAB ML 03
Parameter Norm Placebo Placebo ML 03 ML 03
group group after group group after
before research, before research,
research, research,
29 patients 29 patients 28 patients 28 patients
Average speed of
memorizing pictures 10-12 9 16 9 22*
(for 20 s)
Average reading speed 130 126 144 128 162* (words per minute)
Improvement of
audiomotor and visual — — 11 (38%) — 26 (93%)
calculation
Increase in attention
focusing and set- — — 14 (48%) — 26 (93%)
shifting
* Accurate changes in comparison with the placebo group.
91 // Health territory. PEPTIDES. Memory, intelligence and vision
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.